186 related articles for article (PubMed ID: 6877546)
21. Prolactin secreting pituitary carcinoma.
Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
[TBL] [Abstract][Full Text] [Related]
22. Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat.
Prysor-Jones RA; Jenkins JS
J Endocrinol; 1981 Mar; 88(3):463-9. PubMed ID: 7217831
[TBL] [Abstract][Full Text] [Related]
23. Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.
Breidahl HD; Topliss DJ; Pike JW
Br Med J (Clin Res Ed); 1983 Aug; 287(6390):451-2. PubMed ID: 6411170
[TBL] [Abstract][Full Text] [Related]
24. Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas.
Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C
Br Med J (Clin Res Ed); 1985 Jan; 290(6462):117-8. PubMed ID: 3917709
[No Abstract] [Full Text] [Related]
25. Bromocriptine: Does it jeopardise the result of later surgery for prolactinomas?
Landolt AM; Keller PJ; Froesch ER; Mueller J
Lancet; 1982 Sep; 2(8299):657-8. PubMed ID: 6125789
[No Abstract] [Full Text] [Related]
26. Rapid shrinkage of a prolactin-secreting pituitary tumor with bromocriptine: CT documentation.
Chernow B; Buck DR; Early CB; Ray J; O'Brian JT
AJNR Am J Neuroradiol; 1982; 3(4):442-3. PubMed ID: 6810677
[No Abstract] [Full Text] [Related]
27. [Treatment of prolactin-secreting pituitary tumors with bromocriptine].
Katzir D; Rosenberg T; Ramot Y; Gaver-Shavit A; Gilboa Y
Harefuah; 1990 Feb; 118(3):141-5. PubMed ID: 2341064
[TBL] [Abstract][Full Text] [Related]
28. Effects of bromocriptine on prolactin-secreting pituitary adenomas. Mechanism of reduction in tumor size evaluated by light and electron microscopic, immunohistochemical, and morphometric analysis.
Mori H; Mori S; Saitoh Y; Arita N; Aono T; Uozumi T; Mogami H; Matsumoto K
Cancer; 1985 Jul; 56(2):230-8. PubMed ID: 4005795
[TBL] [Abstract][Full Text] [Related]
29. Recurrent prolactinoma and meningioma following irradiation and bromocriptine treatment.
Kolodny J; Dluhy RG
Am J Med; 1985 Jan; 78(1):153-5. PubMed ID: 3966480
[TBL] [Abstract][Full Text] [Related]
30. Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression.
Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C
Br J Obstet Gynaecol; 1980 Jun; 87(6):523-9. PubMed ID: 7397087
[TBL] [Abstract][Full Text] [Related]
31. Management of extra-sellar pituitary tumours with bromocriptine: comparison of prolactin secreting and non-functioning tumours using half-field visual evoked potentials and computerised tomography.
Pullan PT; Carroll WM; Chakera TM; Khangure MS; Vaughan RJ
Aust N Z J Med; 1985 Apr; 15(2):203-8. PubMed ID: 3861164
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the elution pattern of the serum and CSF prolactin fractionated by gel filtration chromatography in cases of bromocriptine-resistant prolactinoma].
Sakamoto T; Kowada M; Hasegawa H; Ishino Y; Mineura K; Wakisaka A; Fukushima M
Neurol Med Chir (Tokyo); 1987 Mar; 27(3):195-201. PubMed ID: 2442642
[No Abstract] [Full Text] [Related]
33. Bromocriptine treatment of prolactin secreting macroadenomas: a radiological, ophthalmological and endocrinological study.
van 't Verlaat JW; Croughs RJ; Hendriks MJ; Bosma NJ; Nortier JW; Thijssen JH
Acta Endocrinol (Copenh); 1986 Aug; 112(4):487-93. PubMed ID: 3751462
[TBL] [Abstract][Full Text] [Related]
34. Influence of previous bromocriptine therapy on surgery for microprolactinoma.
Faglia G; Moriondo P; Travaglini P; Giovanelli MA
Lancet; 1983 Jan; 1(8316):133-4. PubMed ID: 6129452
[No Abstract] [Full Text] [Related]
35. Effect of bromocriptine and pergolide on pituitary tumor size and serum prolactin.
Horowitz BL; Hamilton DJ; Sommers CJ; Bryan RN; Boyd AE
AJNR Am J Neuroradiol; 1983; 4(3):415-7. PubMed ID: 6410759
[TBL] [Abstract][Full Text] [Related]
36. Effect of tamoxifen on growth and prolactin secretion of rat pituitary tumours.
Prysor-Jones RA; Silverlight JJ; Jenkins JS
J Endocrinol; 1983 May; 97(2):261-6. PubMed ID: 6854193
[TBL] [Abstract][Full Text] [Related]
37. Effect of tamoxifen administration on prolactin release by invasive prolactin-secreting pituitary adenomas.
Lamberts SW; Verleun T; Oosterom R
Neuroendocrinology; 1982; 34(5):339-42. PubMed ID: 7078703
[TBL] [Abstract][Full Text] [Related]
38. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
[TBL] [Abstract][Full Text] [Related]
39. Treatment of prolactinoma based on the results of transsphenoidal operations.
Saitoh Y; Mori S; Arita N; Nagatani M; Hayakawa T; Koizumi K; Tanizawa O; Uozumi T; Mogami H
Surg Neurol; 1986 Oct; 26(4):338-44. PubMed ID: 3750191
[TBL] [Abstract][Full Text] [Related]
40. Rapid decompression of anterior intracranial visual pathways with bromocriptine.
Grimson BS; Bowman ZL
Arch Ophthalmol; 1983 Apr; 101(4):604-6. PubMed ID: 6838419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
